Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2020-12-17 17:45 |
AMOEBA ANNOUNCES THE APPOINTMENT OF PIERRE MORGON AS CENSEUR ON THE BOARD OF DI…
|
English | PDF • 225.5 KB | ||
| 2020-12-09 17:45 |
AMOEBA SIGNE UN ACCORD DE DEVELOPPEMENT ET DE COMMERCIALISATION EXCLUSIF EN FRA…
|
French | PDF • 267.1 KB | ||
| 2020-12-09 17:45 |
AMOEBA SIGNS AN EXCLUSIVE DEVELOPMENT AND MARKETING AGREEMENT IN FRANCE WITH PH…
|
English | PDF • 229.4 KB | ||
| 2020-12-07 17:45 |
AMOEBA ETEND AUX ETATS-UNIS LES TESTS DE SES PRODUITS DE BIOCONTROLE AVEC LE GR…
|
French | PDF • 245.8 KB | ||
| 2020-12-07 17:45 |
AMOEBA EXTENDS TO THE U.S.A. THE TESTING OF ITS BIOCONTROL PRODUCTS WITH THE US…
|
English | PDF • 205.9 KB | ||
| 2020-12-04 17:45 |
AMOEBA annonce l’émission de la neuvième tranche de 26 obligations convertibles…
|
French | PDF • 371.0 KB | ||
| 2020-12-04 17:45 |
AMOEBA announces the issuance of the ninth tranche of 26 bonds convertible into…
|
English | PDF • 314.1 KB | ||
| 2020-12-03 17:45 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 242.8 KB | ||
| 2020-11-16 14:30 |
AMOEBA PUBLIE UN NOUVEL ARTICLE SCIENTIFIQUE DANS LA REVUE MICROORGANISMS
|
French | PDF • 149.2 KB | ||
| 2020-11-16 14:30 |
AMOÉBA PUBLISHES A NEW SCIENTIFIC PAPER IN THE JOURNAL MICROORGANISMS
|
English | PDF • 134.4 KB | ||
| 2020-11-06 18:00 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 252.1 KB | ||
| 2020-11-06 17:45 |
AMOEBA annonce l’émission de la huitième tranche de 26 obligations convertibles…
|
French | PDF • 371.2 KB | ||
| 2020-11-06 17:45 |
AMOEBA announces the issuance of the eighth tranche of 26 bonds convertible int…
|
English | PDF • 313.7 KB | ||
| 2020-10-08 17:45 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 246.8 KB | ||
| 2020-10-06 17:45 |
Communiqué - AMOEBA annonce l’émission de la septième tranche de 26 obligations…
|
French | PDF • 366.4 KB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
